We are live on ! Find out more
INBS icon

Intelligent Bio Solutions
INBS

8 hedge funds and large institutions have $108K invested in Intelligent Bio Solutions in 2024 Q4 according to their latest regulatory filings, with 3 funds opening new positions, 4 increasing their positions, 0 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more funds holding

Funds holding: 8 → 8 (0)

0% more first-time investments, than exits

New positions opened: 3 | Existing positions closed: 3

0.42% less ownership

Funds ownership: 0.59% → 0.18% (-0.42%)

75% less capital invested

Capital invested by funds: $437K → $108K (-$329K)

Holders
8
Holders Change
–
Holders Change %
0%
% of All Funds
0.11%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
4
Reduced
–
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
TSS
Two Sigma Securities
New York
+$23.5K
2
GSC
Ground Swell Capital
South Carolina
+$15.9K
3
TRCT
Tower Research Capital (TRC)
New York
+$7.23K
4
Geode Capital Management
Geode Capital Management
Massachusetts
+$5.93K
5
UBS Group
UBS Group
Switzerland
+$2.06K

Top Sellers

Rank Fund Capital Flow
1
Alyeska Investment Group
Alyeska Investment Group
Illinois
-$357K
2
ACM
ADAR1 Capital Management
Texas
-$9.32K

INBS Hedge Fund Activity: Q4 2024 in Review

8 of the 7,607 institutional investors tracked by Wall St. Rank reported a position in Intelligent Bio Solutions (INBS) for Q4 2024, worth a combined $108K — down 75% from $437K a quarter earlier.

Fund positioning in INBS was balanced in Q4 2024: 3 funds opened new positions, 3 closed out, 4 added to existing stakes and 0 trimmed.

The largest buyer was Two Sigma Securities, opening a new position worth an estimated $23.5K. The largest seller was Alyeska Investment Group, exiting entirely with an estimated $357K sold.

  • 8 institutional investors held Intelligent Bio Solutions (INBS) as of Q4 2024, unchanged from Q3 2024.
  • Funds reported $108K of Intelligent Bio Solutions stock for Q4 2024, down 75% quarter-over-quarter.
  • 3 funds opened new Intelligent Bio Solutions positions in Q4 2024 and 3 closed out, a net change of 0 holders.
  • The largest Intelligent Bio Solutions buyer in Q4 2024 was Two Sigma Securities, an estimated $23.5K added.
  • The largest Intelligent Bio Solutions seller in Q4 2024 was Alyeska Investment Group, an estimated $357K sold.

Based on aggregated 13F filings for Q4 2024.